Effects of interleukin-11 on carboplatin-induced thrombocytopenia in rats and in combination with stem cell factor

International Journal of Hematology

Volumn 65, Issue 4, 1997, Pages 397-404

  Yonemura, Yuji ^a   Kawakita, Makoto ^a   Miyake, Hirosada ^a   Miyazoe, Takako ^a   Fujimoto, Koji ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Carboplatin; Interleukin 11; Stem cell factor; Thrombocytopenia; Thrombopoiesis

Indexed keywords

BOVINE SERUM ALBUMIN; CARBOPLATIN; HEMOGLOBIN; RECOMBINANT INTERLEUKIN 11; RECOMBINANT STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEGAKARYOPOIESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0031172137     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(96)00573-7     Document Type: Article

References (27)

1. [1] Lok S, Kaushansky K, Holly R et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
2. [2] de Sauvage FJ, Hass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
3. [3] Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
4. [4] Kato T, Ogami K, Shimada Y et al. Purification and characterization of thrombopoietin. J Biochem 1995;118:229-236.
5. [5] Ulich TR, del Castillo J, Yin S et al. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995;86:971-976.
6. [6] Gordon MS, Hoffman R. Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood 1992;80:302-307.
7. [7] Ishibashi T, Kimura H, Uchida T, Karione S, Friese P, Burstein SA. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 1989;86:5953-5957.
8. [8] Bruno E, Hoffman R. Effect of interleukin 6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines. Exp Hematol 1989;17:1038-1043.
9. [9] Ishibashi T, Kimura H, Shikama Y et al. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 1989;74:1241-1244.
10. [10] Asano S, Okano A, Ozawa K et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 1990;75:1602-1605.
11. [11] Patchen ML, MacVittie TJ, Williams JL, Schwartz GN, Souza LM. Administration of interleukin-6 stimulated multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 1991;77:472-480.
12. [12] Paul SR, Bennett F, Calvetti JA et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990;87:7512-7516.
13. [13] Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Kato K, Takatsuki K. Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. Exp Hematol 1992;20:1011-1016.
14. [14] Bruno E, Briddell RA, Cooper RJ, Hoffman R. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol 1991;19:378-381.
15. [15] Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H. Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 1992;79:327-331.
16. [16] Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Takatsuki K. Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: comparative study with interleukin-6. Br J Haematol 1993;84:16-23.
17. [17] Muggia FM. Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin. Semin Oncol 1989;16(Suppl 5):7-13.
18. [18] Migliaccio G, Migliaccio AR, Valinsky J et al. Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci USA 1991;88:7420-7424.
19. [19] Andrews RG, Knitter GH, Bartelmez SH et al. Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 1991;78:1975-1980.
20. [20] Briddell RA, Bruno E, Cooper RJ, Brandt JE, Hoffman R. Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood 1991;78:2854-2859.
21. [21] Tsuji K, Lyman SD, Sudo T, Clark SC, Ogawa M. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 1992;79:2855-2860.
22. [22] Du XX, Keller D, Maze R, Williams DA. Comparative effects of in vivo treatment using interleukin-11 and stem cell factor on reconstitution in mice after bone marrow transplantation. Blood 1993;82:1016-1022.
23. [23] Leonard JP, Quinto CM, Kozita MK, Neben TY, Goldman SJ. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 1994;83:1499-1506.
24. [24] Nash RA, Seidel K, Storb R et al. Effects of rhIL-11 on normal dogs and after sublethal radiation. Exp Hematol 1995;23:389-396.
25. [25] Cairo MS, Plunkett JM, Schendel P, van de Ven C. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count. Exp Hematol 1994;22:1118-1123.
26. [26] Tepler I, Elias L, Smith JW et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996;87:3607-3614.
27. [27] Gordon MS, McCaskill-Stevens WJ, Battiato LA et al. A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996;87:3615-3624.